A Chimeric Platelet-Targeted Urokinase Prodrug Selectively Blocks New Thrombus Formation

Journal of Clinical Investigation - United States
doi 10.1172/jci81470
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Quantification of Platelet Contractile Movements During Thrombus Formation

Thrombosis and Haemostasis
Hematology
2018English

Clinical Aspects of Platelet Inhibitors and Thrombus Formation

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2007English

RhoG Protein Regulates Platelet Granule Secretion and Thrombus Formation in Mice

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2013English

Dynamics of GPIIb/IIIa-mediated Platelet-Platelet Interactions in Platelet Adhesion/Thrombus Formation on Collagen in Vitro as Revealed by Videomicroscopy

Blood
BiochemistryImmunologyCell BiologyHematology
2003English

Ruthenium-Conjugated Chrysin Analogues Modulate Platelet Activity, Thrombus Formation and Haemostasis With Enhanced Efficacy

Scientific Reports
Multidisciplinary
2017English

Inhibited and Uninhibited Platelet Deposition Within a Thrombus: Figure.

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2015English

Dynamic and Structural Formation of a Thrombus

Journal of Child Neurology
Child HealthNeurologyPediatricsPerinatology
2011English

Adenoviral Expression of a Urokinase Receptor-Targeted Protease Inhibitor Inhibits Neointima Formation in Murine and Human Blood Vessels

Circulation
Cardiovascular MedicinePhysiologyCardiology
2001English

P142 ROS101, a Novel Targeted Methotrexate Prodrug, Selectively Activated by Reactive Oxygen Species (ROS) Shows Reduced Toxicity in Rat CIA Model of Rheumatoid Arthritis

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy